← Back to Screener
Drugs Made In America Acquisition II Corp. Unit (DMIIU)
Price$10.08
Favorite Metrics
Price vs S&P 500 (4W)-7.84%
Market Capitalization$637.64M
All Metrics
Book Value / Share (Quarterly)$7.36
Price vs S&P 500 (YTD)-1.33%
10-Day Avg Trading Volume0.07M
EPS (Annual)$-0.01
Cash / Share (Quarterly)$0.00
ROA (Last FY)-219.79%
Cash Flow / Share (Annual)$-0.01
P/B Ratio1.32x
P/B Ratio (Quarterly)1.05x
EPS Incl Extra (Annual)$-0.01
Current Ratio (Annual)0.23x
Quick Ratio (Quarterly)1.30x
3-Month Avg Trading Volume0.11M
52-Week High$10.01
EPS Excl Extra (Annual)$-0.01
Quick Ratio (Annual)0.07x
13-Week Price Return0.91%
Current Ratio (Quarterly)1.32x
Enterprise Value$637.322
Cash / Share (Annual)$0.00
3-Month Return Std Dev2.08%
EPS Basic Excl Extra (Annual)$-0.01
Total Debt / Equity (Quarterly)0.00x
Revenue / Share (Annual)$0.00
Year-to-Date Return1.11%
5-Day Price Return0.00%
EPS Normalized (Annual)$-0.01
Month-to-Date Return0.40%
EBITD / Share (Annual)$-0.01
Price vs S&P 500 (13W)-1.47%
Beta0.01x
52-Week Low$9.86
Industry Peers — Blank Checks / SPACs(334)
| Symbol | P/E Ratio (Annual) | Indicated Dividend Yield (Annual) | ROE (TTM) | P/B Ratio (Quarterly) | Price |
|---|---|---|---|---|---|
DMIIUDrugs Made In America Acquisition II Corp. Unit | — | — | — | 1.05x | $10.08 |
LFACLeapfrog Acquisition Corporation Class A Ordinary Shares | 720.81x | — | 1.92% | 2.80x | $9.95 |
LFACULeapfrog Acquisition Corporation Units | 720.81x | — | 1.92% | 2.80x | $10.05 |
AACIArmada Acquisition Corp. III Class A Ordinary Share | — | — | -9.52% | 14.61x | $9.90 |
BEAGBold Eagle Acquisition Corp. Class A Ordinary Shares | 61.97x | — | 3.80% | 2.33x | $10.53 |
BEAGRBold Eagle Acquisition Corp. Right | 61.97x | — | 3.80% | 2.33x | $0.24 |
BEAGUBold Eagle Acquisition Corp. Units | 61.97x | — | 3.80% | 2.33x | $10.74 |
BCSSBain Capital GSS Investment Corp. | 139.57x | — | — | 1.31x | $10.18 |
BCSS.UBain Capital GSS Investment Corp. Units, each consisting of one Class A Ordinary Share and one-fifth of one redeemable warrant | 139.57x | — | — | 1.31x | $10.39 |
CEPFCantor Equity Partners IV, Inc. Class A Ordinary Shares | 95.72x | — | — | 1.29x | $10.26 |
KRSPRice Acquisition Corporation 3 | 172.51x | — | — | 1.41x | $10.30 |
About
Drugs Made In America Acquisition II Corp is a special purpose acquisition company (SPAC) seeking to combine with an operating company in the pharmaceutical industry. The company provides capital and a path to public markets for qualified acquisition targets in the U.S. pharmaceutical sector.